Both in Biotechnology
Prime Medicine vs MeiraGTx Holdings
Over the past year PRME returned +15.6% and MGTX returned +10.0%; their daily moves had a correlation of 0.41.
PRME +15.6% MGTX +10.0%Growth of $1, one year, split-adjusted
| Metric | PRME | MGTX |
|---|---|---|
| Price | $4.97 | $9.42 |
| Market cap | $901.4M | $904.7M |
| Today | +9.23% | −1.05% |
| 1 month | +42.0% | −11.1% |
| 6 months | +45.7% | −4.8% |
| Year to date | +43.2% | +18.5% |
| 1 year | +9.0% | +7.9% |
| Revenue growth (YoY) | +3.5% | +8608.6% |
| Gross margin | 100.0% | 97.8% |
| Net margin | −3649.0% | 50.0% |
| P/E (TTM) | — | 11.5× |
| Price / sales | 221.3× | 2.3× |
| Net cash | $95.1M | $21.8M |
| Dividend yield | — | — |
| Volatility (60d) | 112.8% | 47.5% |
| Short % of float | 34.4% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).